According to a new report by Polaris Market Research, the global Specialty Enzymes Market was valued at USD 6.20 billion in 2024 and is projected to reach USD 13.86 billion by 2034, expanding at a CAGR of 8.4% from 2025 to 2034. Growth is underpinned by advances in AI-driven enzyme engineering, expanding public and private biotechnology funding, and rising demand for enzyme-based solutions across pharmaceuticals, diagnostics, and industrial biocatalysis.

What Is Driving Specialty Enzymes Market Growth?

Demand is climbing as artificial intelligence and machine learning converge with expanding biotechnology investment to accelerate enzyme discovery. Biotechnology companies are increasingly using AI and ML to forecast optimal enzyme candidates for experimental screening — in December 2023, genome-engineering firm Neochromosome partnered with the University of Edinburgh's Dr. Giovanni Stracquadanio to apply AI and ML to designer enzyme development. Polaris analysts note that public funding is reinforcing this trajectory: the EU's Horizon Europe program allocated USD 100.9 billion for 2021–2027 with a biotechnology focus, while the US National Institutes of Health directed more than USD 45.0 billion to biomedical research in 2022, positioning the market for sustained growth through 2034, with pharmaceuticals emerging as the largest application and proteases posting the strongest incremental gains by type.

Key Trends Shaping the Specialty Enzymes Industry

AI-Enabled Enzyme Engineering Accelerating Discovery

Artificial intelligence and deep learning are increasingly embedded in enzyme development, enabling rapid analysis and prediction of enzyme properties, structures, and functions. This technology advancement is helping biotechnology companies mitigate the limitations of traditional screening approaches and shorten the path from candidate identification to commercial enzyme products.

Innovative Product Launches Expanding Application Range

Biotechnology companies continue to introduce advanced, high-performance enzymes tailored to specific industries. Novonesis's March 2025 launch of Progress Beyond and Progress Go protease enzymes for cold-wash laundry detergents, and AB Enzymes' October 2024 introduction of VERON POLARUM baking lipase, illustrate how formulation innovation is broadening enzyme use across consumer and industrial applications alike.

Expanding Bioscience Industry Widening the Application Base

The bioscience sector's rapid expansion — contributing USD 2.9 trillion to the US economy in 2021, according to the Biotechnology Innovation Organization — is broadening the scope of enzyme applications across pharmacogenomics, proteomics, and synthetic biology. This market outlook driver is stimulating continuous technological advancement and reinforcing demand for enzymes with enhanced precision and efficacy.

Market Segmentation: Breaking Down the Specialty Enzymes Market

Polaris segments the Specialty Enzymes Market by source, type, form, application, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Type

The proteases segment is projected to register a significant CAGR over the forecast period, reflecting the essential role and versatility of proteolytic enzymes across pharmaceuticals, agriculture, and food processing. In drug formulation and protein-based therapies specifically, proteases are increasingly central to pharmaceutical manufacturing, with rising drug discovery activity and biotechnology advancement expected to drive robust growth in this type category through 2034.

By Application

The pharmaceuticals segment held the largest revenue share in 2024, driven by growth in global drug development and production. India's pharmaceutical industry, for example, ranks third globally in production by volume and has grown at a CAGR of 9.43%, according to the India Brand Equity Foundation. This worldwide pharma expansion is reinforcing demand for specialty enzymes used in drug synthesis, purification, and formulation.

By Source and Form

The report also tracks the market across animal, microorganism, and plant-based enzyme sources, as well as dry and liquid enzyme forms, giving manufacturers and buyers visibility into sourcing and formulation trends that shape production costs and application suitability across end markets.

Regional Outlook: Where Is the Specialty Enzymes Market Growing Fastest?

North America accounted for the largest revenue share in 2024, driven by the presence of established biotechnology and diagnostics firms such as Codexis, Inc., Dyadic International Inc., SEKISUI Diagnostics, and Thermo Fisher Scientific, whose R&D investment and strategic collaborations have reinforced the region's pharma-driven enzyme demand. Asia Pacific is projected to register a substantial CAGR during the forecast period, fueled by advancements in genomics and proteomics — including SOPHiA GENETICS' May 2024 collaboration with Microsoft and NVIDIA on scalable whole genome sequencing analysis. Within Asia Pacific, China is expected to see significant growth, supported by regulatory initiatives such as the 14th Five-Year Plan, which streamlines approval processes and channels investment into biotech research infrastructure.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/specialty-enzymes-market 

Competitive Landscape: Leading Specialty Enzymes Companies

Key players profiled in the report include 4basebio, Advanced Enzyme Technologies, Amano Enzyme Inc., Aumgene Biosciences, BASF SE, BBI Solutions, Bioseutica, Codexis, Inc., Dyadic International Inc, Enzyme Bioscience Private Limited, F. Hoffmann-La Roche Ltd, Merck KGaA, New England Biolabs, S.I. Biozyme, Sanofi, SEKISUI Diagnostics, and Thermo Fisher Scientific Inc., who are focusing on R&D investment, manufacturing expansion, and strategic collaborations to strengthen market position across the pharmaceuticals and proteases segments outlined above. Recent moves include Amano Enzyme's July 2024 memorandum of understanding with Vietnam National University to advance enzyme and protein technology research, and Novus International's March 2024 acquisition of BioResource International to broaden its enzyme innovation capabilities.

Why It Matters for Stakeholders Evaluating Market Entry

For stakeholders researching Specialty Enzymes Market entry into industrial biocatalysis, this report benchmarks market share, segment-level data, and forecast figures — by source, type, form, application, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking diagnostics and research & biotechnology applications as growth adjacencies alongside the dominant pharmaceuticals segment.

More Trending Latest Reports By Polaris Market Research:

Hand Dryer Market

Electric Aircraft market

Software Consulting Market

Protein A, G, and L Resins Market

Electric Aircraft market

Automotive Tire Market

Bone Wax Market

Unlocking Insights: Exploring the Urinalysis Market

U.S. Real-time Location Systems Market